SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-056292
Filing Date
2024-05-09
Accepted
2024-05-09 08:00:13
Documents
12
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nams-20240509.htm   iXBRL 8-K 50343
2 EX-99.1 nams-ex99_1.htm EX-99.1 300658
  Complete submission text file 0000950170-24-056292.txt   529420

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20240509.xsd EX-101.SCH 54813
15 EXTRACTED XBRL INSTANCE DOCUMENT nams-20240509_htm.xml XML 6453
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 24928661
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)